Abstract In the first part of this paper, gut microbial difference of two genotypes mice was researched. The gut microbial community of type 2 diabetes animal model KKAy mice and normal C57BL/6J mice had clear distinctions in DGGE (denaturing gradient gel electrophoresis) profiles. The pairwise similarity coefficient (C s ) was only 26-44 % between KKAy and C57BL/6J, but C s was 82-100 % among same genotypes mice. Thirteen dominant bands were cloned from DGGE profiles to exhibit difference on gut microbial structure further. In the second part of this paper, the influence of hypoglycemic drug Pioglitazone on the gut microbes in KKAy mice was researched by gut microbial diversity analysis and principal component analysis (PCA). The results showed that Pioglitazone reduced the gut microbial diversity slightly and changed gut microbial structure of KKAy mice to that of normal C57BL/6J mice.
Introduction
KKAy mice, due to gene mutation, were the spontaneous animal model of hyperglycemia and hyperlipidemia, and their symptoms are similar to that of type 2 diabetes. Type 2 diabetes was caused by metabolic disorders. The gut microbes participated directly and indirectly in the metabolism of the host. Yadav et al. [1] discovered that Lactobacillus could lower plasma glucose and LDL (low-density lipoprotein), and alleviate the type 2 diabetes effectively. Disordered microbial community would aggravate the metabolic abnormalities, which could accelerate the development of hyperglycemia and led to other complications of the patient. Some reports indicated that Rikenella and Odoribacter present in ceca of db/db mice which were a model for diabetic dyslipidemia [2] . Barnesiella were increased in fasting hyperglycaemia and high plasma concentration of pro-inflammatory cytokines mice [3] .
The human gut is colonized with an enormous variety and amount of microorganisms, dramatically affecting human physiology and pathology [4] . The entire cohort harbors more than 1,000 prevalent bacterial species. The gene set of gut microbes is about 150 times overwhelmingly larger than the human gene complement [5] . So some scholars believe that gut microbes can be pictured as a microbial organ or an environmental factor, influencing and regulating the host [6, 7] . If we only focus on the blood glucose and ignore gut microbes of the patient, we might miss the optimal scheme of treatment for type 2 diabetes. Therefore the microbes, which were associated with diabetes, were identified by researching gut microbial differences of two genotypes mice and the influence of drug on gut microbes in our paper.
Materials and Methods

Animals
KKAy and C57BL/6J mice (female, 10 weeks) were bought from Institute of Laboratory Animal Sciences, CAMS&PUMC. They were maintained in the animal room of Shanxi Hospital of Traditional Chinese Medicine under specific pathogen free conditions (SPF) and allowed free access to food and water. The 12 KKAy mice were randomly divided into two groups (six in each group), drug group (Pioglitazone by gavage) and control group (equal distilled water by gavage), and there were six C57BL/6J mice as a normal group (equal distilled water by gavage). Each animal was contained in its own cage. All procedures were approved by the Institutional Animal Care and Use Committee of the Shanxi Hospital of Traditional Chinese Medicine.
Sample Collection and the Extraction of Total DNA Fresh faecal samples were collected separately into sterile centrifuge tubes and were immediately stored at -20°C. In accordance with the method [8] , the genomic DNA of gut microbes were extracted.
16S rDNA V3 Region PCR Amplification and DGGE V3 region of 16S rDNA of gut microbes was amplified twice from diluted DNA using universal primers. The first PCR used Touchdown protocol described by Korbie and Mattick [9] . The second PCR used Reconditioning PCR with the 1st PCR products as a template [10] . DGGE was performed with Bio-Rad Dcode system (Bio-Rad, Hercules, CA, USA). The gradient of denaturing gel was from 32 to 58 %, PCR product was 200 ng on every lane and the electrophoresis lasted for 4 h (200 V, 60°C). The results of electrophoresis were tested by silver staining method [11] and photographed with UVI (UVItec, Cambridge, UK) system.
Similarity Analysis of Different Samples
Samples similarity was analyzed by pairwise similarity coefficient (C s ): C s = 2j/(a ? b) 9 100 %. Two completely different DGGE profiles had a C s value of 0 %, and two identical profiles had a C s value of 100 % [12] .
Gut Microbial Diversity Analysis by Optical Density
The relative intensities of bands could be used to infer the relative abundance of population [13] . The diversity of gut microbes was described by Shannon-Weaver index (diversity index, H 0 ), 
where ni was the peak area of band i, N was the sum of all bands' peak areas on this lane [14] .
Principal Component Analysis of DGGE Profile
Two-dimensional matrix of relative intensities and the location of bands on DGGE profile were analyzed by Quantity One Ò v4.4, and principal component analysis (PCA) was performed using the Matlab7.0 program.
Clone and Sequencing of DGGE Bands
The DNA of DGGE band was eluted in 100 ll sterile water. The eluted DNA was re-amplified using same conditions as described above. The PCR products were cloned (pMD18-T vector, Takara Bio). The positive clones of each band were sequenced (Sangon Biotech, Shanghai) and the results were compared with GenBank database by BLAST.
Nucleotide Sequence Accession Number
The partial sequences of 16S rRNA genes from key DGGE bands obtained in this study were deposited in GenBank with the following accession numbers: JX103599-JX103635. 
Results
Analysis of DGGE Profiles
Similarity Analysis of Different Samples
Among KKAy mice C s = 82-100 %, C57BL/6J mice C s = 83-94 %, and the different genotypes mice C s = 26-44 %. Much less similarities were showed between different genotypes, perhaps because genotypes led to diversity in physiology and metabolism, which then led to differences in gut microbial community [15] .
Sequencing of Fragments and Phylogenetic Analysis
Thirteen dominant bands (marked A-M at Fig. 1) were cloned from DGGE profiles and 3-6 clones were Fig. 3 The gut microbial diversity among groups in different times (10d* 10 days before drug, 10d-70d 10-70 days after drug) The sequences compared results in GenBank had 15 uncultured bacteria which were unclassified. All sequences were newly compared in RDP database. These uncultured bacteria were classified through taxonomy with phylogeny in RDP database and the others were the same with compared results in GenBank. Taxon represented the lowest taxonomic unit in compared results sequenced for every band. Forty-five sequences were obtained in total, and among which 24 belonged to KKAy mice, 18 to C57BL/6J mice, 3 to common. All sequences felled into four Phylum (Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria), compared by GenBank and RDP database ( Table 1) .
The results of phylogenetic analysis (Fig. 2) [16] by neighbor-joining method by MEGA 5.05, were the same as that of compared. Among all sequences, 27 belonged to Bacteroidetes, 13 to Firmicutes, 4 to Proteobacteria and 1 to Actinobacteria. Therefore, the dominant gut microbes of the two genotypes fell into Bacteroidetes and Firmicutes.
Gut Microbial Diversity Analysis
Calculate the diversity index H 0 of each sample, and use the average of each group at same period to evaluate the group gut microbial diversity. The H 0 of normal group was slightly higher than that of control group and drug group at the beginning. The former remained stable, but the latter gradually declined. Unexpectedly, the microbial diversity of the drug group was lower than the control group (Fig. 3) . We inferred that the gut microbes were influenced not only by metabolic abnormalities of KKAy mice itself, but also the drug. The interference of drug on gut microbes resulted in further enrichment of some bacteria, but others lost, or Pioglitazone had the antibacterial effect, resulting in gut microbial diversity decreasing.
Principal Component Analysis
In order to better exhibit changes of gut microbial community structure at different periods, PCA of DGGE profiles were performed by digital matrixes (Fig. 4) . The drug group gradually moved close to the normal group. And 70 days after drug, two groups merged along the PC1 axis. In the meantime, control group moved away along the PC1 axis and separated itself. So Pioglitazone could make gut microbes structure close to normal, somewhat improve microbial structure in gut.
Discussion
In our research, the difference of gut microbial structure between KKAy mice and C57BL/6J mice infer that gut microbes is an important factor for type 2 diabetes, and there is an obvious correlation between gut microbes and host genotypes. The difference in structure of gut microbes is extremely important for exploring their physiological functions. The 16S rDNA fragments of Bacteroides, Facklamia, Alistipes, Rikenella, Odoribacter and Anaerotruncus are discovered from intestine of KKAy mice. The fragments of Barnesiella, Desulfovibrio, Pseudomonas, Lachnospiraceae, Porphyromonadaceae and Microbacteriaceae are obtained from sample of C57BL/6J mice. The two species of mice share common gut microbes, including Lactobacillus, Acetivibrio and Prevotella. Bacteroides is a prominent group in KKAy mice. Its capacity for digesting indigestible dietary polysaccharides is prodigious. The type strain (ATCC 29148) of Bacteroides thetaiotaomicron only has 6.3 Mb genome sequence, but these genes can code 226 predicted glycoside hydrolases, 163 digesting starch proteins and 15 polysaccharide lyases [6] . Band B from KKAy, is similar with a series of uncultured bacteria which are beneficial for mice to express TLR4 on intestinal mucosa [8] . TLR4 triggers the activation of kinase cascades and stimulates signaling pathways of inflammation in cells for prompted insulin resistance [17] . In our experiment, only one bacterium, from C57BL/6J, belongs to Actinobacteria. At present, there are few reports about Actinobacteria in mice intestine. Marine actinobacteria can produce a-glucosidase enzyme inhibitor as clinical tool for treating diabetes [18] . The difference of gut microbes from two genotypes mice is not accidental. Some of them closely linked with the type 2 diabetes. We concluded that effect of gut microbes on diabetes had two critical respects. First, gut microbes ferment indigestible polysaccharides for blood glucose. Second, they promote the release of inflammatory factors which are an early factor in the triggering of insulin resistance [19] .
